Bio-Path Holdings Reports Full Year 2023 Financial Results
“2023 was a year of focused execution, as evidenced by the continued progress across our pipeline of DNAbilize programs,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings.
- “2023 was a year of focused execution, as evidenced by the continued progress across our pipeline of DNAbilize programs,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings.
- As of December 31, 2023, the Company had cash of $1.1 million, compared to $10.4 million as of December 31, 2022.
- Net cash provided by financing activities for the year ended December 31, 2023 was $2.2 million.
- ET to review these full-year 2023 financial results and to provide a general update on the Company.